Nature’s Sunshine Products (NASDAQ:NATR) Price Target Raised to $29.00 at Canaccord Genuity Group

Nature’s Sunshine Products (NASDAQ:NATR) had its target price upped by Canaccord Genuity Group from $22.00 to $29.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock.

Several other equities analysts have also recently weighed in on the company. DA Davidson lifted their price target on Nature’s Sunshine Products from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Weiss Ratings reissued a “hold (c+)” rating on shares of Nature’s Sunshine Products in a report on Monday, December 29th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $26.00.

Nature’s Sunshine Products Trading Down 0.2%

Shares of NATR stock opened at $25.08 on Tuesday. The stock has a market capitalization of $438.90 million, a P/E ratio of 30.96 and a beta of 0.94. The firm’s 50 day moving average is $24.90 and its 200 day moving average is $20.34. Nature’s Sunshine Products has a 12 month low of $11.01 and a 12 month high of $28.14.

Nature’s Sunshine Products (NASDAQ:NATR) last released its quarterly earnings data on Tuesday, March 10th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.19 by $0.11. Nature’s Sunshine Products had a net margin of 3.18% and a return on equity of 10.86%. The company had revenue of $123.81 million during the quarter, compared to the consensus estimate of $121.62 million.

Insider Activity at Nature’s Sunshine Products

In related news, EVP Bryant J. Yates sold 1,700 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $22.29, for a total value of $37,893.00. Following the transaction, the executive vice president directly owned 98,604 shares in the company, valued at approximately $2,197,883.16. This represents a 1.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 5.60% of the company’s stock.

Hedge Funds Weigh In On Nature’s Sunshine Products

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. AWM Investment Company Inc. purchased a new position in Nature’s Sunshine Products in the second quarter worth $5,176,000. Boston Partners bought a new stake in Nature’s Sunshine Products during the fourth quarter worth about $4,544,000. Kennedy Capital Management LLC boosted its holdings in shares of Nature’s Sunshine Products by 37.2% in the 2nd quarter. Kennedy Capital Management LLC now owns 589,636 shares of the company’s stock worth $8,721,000 after purchasing an additional 160,002 shares in the last quarter. CSM Advisors LLC purchased a new position in shares of Nature’s Sunshine Products in the 2nd quarter worth about $1,977,000. Finally, Manatuck Hill Partners LLC bought a new position in shares of Nature’s Sunshine Products during the 2nd quarter valued at about $1,923,000. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Nature’s Sunshine Products News Roundup

Here are the key news stories impacting Nature’s Sunshine Products this week:

• Positive Sentiment: Q4 beat: NATR reported EPS of $0.30 vs. consensus $0.19 and revenue of $123.8M vs. $121.6M, showing both top‑ and bottom‑line beat that supports near‑term earnings momentum. Nature’s Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results
• Positive Sentiment: Upside FY‑2026 revenue guidance: the company gave revenue guidance of $500.0M–$515.0M versus consensus ~$494.4M, implying continued top‑line growth that can validate the stock’s premium multiple. Nature’s Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results
• Positive Sentiment: Analyst lift: Canaccord raised its price target to $29 and reiterated a Buy, adding upward analyst momentum and signaling ~15% upside from recent levels. Canaccord price target raise (Benzinga)
• Neutral Sentiment: Management commentary & details available: the full earnings call transcript and slide deck are posted — useful for parsing margin drivers, regional trends and any non‑GAAP adjustments. Q4 2025 Earnings Call Transcript (Seeking Alpha)
• Neutral Sentiment: Press materials and slides: company press release and slide deck are posted for investors to review segment performance and guidance assumptions. Press Release / Slide Deck
• Neutral Sentiment: Pre‑earnings coverage and previews appeared across outlets (Yahoo, MSN, 247WallSt) — helpful context but not materially new given the company release. Wall Street Lifts Targets (247WallSt)

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.